Home 5 Resource Product: Microglia
High-Throughput Screening of FDA-Approved Compounds Identifies Modulators of Phagocytic Activity in iPSC-Derived Microglia (SfN 2025)

High-Throughput Screening of FDA-Approved Compounds Identifies Modulators of Phagocytic Activity in iPSC-Derived Microglia (SfN 2025)

Patient-Derived iPSC Neuronal Models Reveal Alzheimer’s Disease-Associated Pathology and Provide a Platform for Drug Discovery (SfN 2025)

Patient-Derived iPSC Neuronal Models Reveal Alzheimer’s Disease-Associated Pathology and Provide a Platform for Drug Discovery (SfN 2025)

Quick-Glia™ Microglia – Maintenance Medium

Quick-Glia™ Microglia – Maintenance Medium

Quick-Glia™ Microglia – Human iPSC-Derived Microglia

Quick-Glia™ Microglia – Human iPSC-Derived Microglia

Predicting Clinical Efficacy with Alzheimer’s Disease iPSC Panels

Predicting Clinical Efficacy with Alzheimer’s Disease iPSC Panels

Unlocking the Secrets of Alzheimer’s, Epilepsy, and More with Cutting-Edge iPSC Technology

Unlocking the Secrets of Alzheimer’s, Epilepsy, and More with Cutting-Edge iPSC Technology

Rapid Differentiation of Functional Microglia from Human iPSCs by Transduction of Transcription Factors Using Sendai Virus (Society for Neuroscience 2023)

Rapid Differentiation of Functional Microglia from Human iPSCs by Transduction of Transcription Factors Using Sendai Virus (Society for Neuroscience 2023)

No results found.